Seeing Is Believing
ENFN is currently covered by 6 analysts with an average price target of $11.73. This is a potential upside of $1.1 (10.35%) from yesterday's end of day stock price of $10.63.
Enfusion's activity chart (see below) currently has 27 price targets and 31 ratings on display. The stock rating distribution of ENFN is 13.33% BUY, 66.67% HOLD and 20% SELL.
Analysts average stock forecasts to be materialized ratio is 45.6% with an average time for these price targets to be met of 89.13 days.
Highest price target for ENFN is $9, Lowest price target is $8, average price target is $11.73.
Most recent stock forecast was given by KOJI IKEDA from BAML on 13-Mar-2024. First documented stock forecast 15-Nov-2021.
Currently out of the existing stock ratings of ENFN, 2 are a BUY (13.33%), 10 are a HOLD (66.67%), 3 are a SELL (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$9
$-1.63 (-15.33%)
$10
9 months 8 days ago
(13-Mar-2024)
2/4 (50%)
$-0.32 (-3.43%)
87
Sell
$8
$-2.63 (-24.74%)
$10
9 months 23 days ago
(28-Feb-2024)
3/5 (60%)
$-0.73 (-8.36%)
114
Sell
$9
$-1.63 (-15.33%)
$12
10 months 21 days ago
(30-Jan-2024)
1/2 (50%)
$0.97 (12.08%)
17
Hold
$10
$-0.63 (-5.93%)
$9
1 years 1 days ago
(20-Dec-2023)
3/3 (100%)
$0.35 (3.63%)
151
Hold
$9
$-1.63 (-15.33%)
$11
1 years 1 months 14 days ago
(07-Nov-2023)
2/7 (28.57%)
$0.4 (4.65%)
25
What is ENFN (Enfusion) average time for price targets to be met?
Which analyst has the current highest performing score on ENFN (Enfusion) with a proven track record?
Which analyst has the current lower performing score on ENFN (Enfusion) with a proven track record?
Which analyst has the most public recommendations on ENFN (Enfusion)?
Which analyst is the currently most bullish on ENFN (Enfusion)?
Which analyst is the currently most reserved on ENFN (Enfusion)?